alpha-n-acetylgalactosaminidase

Preferred Label : alpha-n-acetylgalactosaminidase;

MeSH definition : A hexosaminidase with specificity for terminal non-reducing N-acetyl-D-galactosamine residues in N-acetyl-alpha-D-galactosaminides.;

MeSH synonym : alpha-d-n-acetyl-galactosaminyloligosaccharidase; alpha-galactosidase b; alpha-d-n-acetylgalactosaminyloligosaccharidase; endo-n-acetyl-alpha-d-galactosamidase; alpha d n acetylgalactosaminyloligosaccharidase; alpha galactosidase b; endo-alpha-n-acetylgalactosaminidase; endo alpha n acetylgalactosaminidase; endo n acetyl alpha d galactosamidase; n-acetyl-alpha-d-galactosaminidase; n acetyl alpha d galactosaminidase; alpha d n acetyl galactosaminyloligosaccharidase; alpha-n-acetyl-d-galactosaminidase; alpha n acetyl d galactosaminidase; alpha N acetylgalactosaminidase;

Registry Number MeSH : EC 3.2.1.49;

Is substance : O;

UNII : EC 3.2.1.49;

Details

Origin ID

D048809;

UMLS CUI

C0051436;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Alpha galactosidase [OBSOLETE LOINC component]
- Alpha-N-acetylgalactosaminidase deficiency [ICD-11 More detail]
- Alpha-galactosidase (substance) [SNOMED CT concept]
- N-acetyl-alpha-D-galactosaminidase [OMIM gene]
- alpha-N-acetylgalactosaminidase [HGNC gene]
- alpha-N-acetylgalactosaminidase [ORDO Gene]
- alpha-galactosidase [SNOMED Notion]
- galactosidase alpha [ORDO Gene]
Record concept(s)
- alpha-N-Acetylgalactosaminidase [MeSH concept]
Related MeSH Supplementary Concept(s)
- NAGA protein, human [MeSH Supplementary Concept]
- alpha-N-acetygalactosaminidase, acremonium [MeSH Supplementary Concept]
- gana-1 protein, C elegans [MeSH Supplementary Concept]
- lysosomal Alpha-N-Acetylgalactosaminidase deficiency [MeSH Supplementary Concept]
- naga protein, mouse [MeSH Supplementary Concept]
- schindler disease, type I [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Enzyme [UMLS semantic type]
UMLS correspondences (same concept)
- Alpha-N-acetylgalactosaminidase [LOINC component]
- N-Acetyl-alpha-galactosaminidase (substance) [SNOMED CT concept]
- alpha-n-acetylgalactosaminidase [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients